January 19, 2018 10:57 PM ET

Pharmaceuticals

Company Overview of The Medicines Company

Executive Profile

John C. Kelly

Independent Director, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 organization across 3 different industries.

See Board Relationships
86$344,025

Background

Mr. John C. Kelly served as Vice President and Controller of Wyeth, LLC. Mr. Kelly served as Senior Vice President of Finance at Pfizer Inc. from October 2009 to February 2010. He served as Vice President of Finance Operations of Wyeth until March 2008. He joined Wyeth in 2002 and handled a wide range of assignments in finance. Mr. Kelly served as a Partner of Arthur Andersen LLP for more than 35 years. Mr. Kelly has over 40 years of experience in accounting and finance, ...

Corporate Headquarters

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships

2009-Present
Independent Director
2011-Present
Independent Director

Education

BS
Seton Hall University
MBA
Seton Hall University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$89,000
Total Calculated Compensation$344,025
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas A. Michels President, CEO & Director
OraSure Technologies, Inc.
$612.3K
John Dawson CEO & Executive Director
Oxford BioMedica PLC
$553.0K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals, Inc.
$689.2K
Saeed Motahari President, CEO & Director
INSYS Therapeutics, Inc.
--
Rick E. Winningham Chairman & CEO
Theravance Biopharma, Inc.
$1.1M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Medicines Company, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.